Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CTI

- PMLiVE

Pfizer’s bid for Hospira could lead to break-up

Questions posed whether $15bn bid will be profitable for the firm

- PMLiVE

AZ and University of Texas to collaborate on cancer research

Studies will aim to improve patient outcomes

- PMLiVE

Pfizer’s Ibrance wins early breast cancer approval in US

FDA’s decision come two months ahead of schedule

- PMLiVE

Products over pipeline in Pfizer’s acquisition targets, hints CEO

Sale forecasts for 2015 are down by up to $5bn compared to last year

- PMLiVE

Novartis launches another localised NHS eye service in UK

Will provide specialised care to people of Coventry

- PMLiVE

Pfizer’s Prevenar 13 price cut slammed by MSF

Global health charity says reduction of 20 cents is "negligible"

Pfizer strikes genetic research deal with 23andMe

Lupus study and research community forms just one part of their collaboration

- PMLiVE

Pfizer names head of Germany business

Peter Albiez has been with pharma company since 1996

- PMLiVE

Call for GSK and Pfizer to reduce vaccine price

MSF campaigns to lower cost of pneumococcal shot to $5 per child in developing countries

- PMLiVE

Boehringer partners with US universities

Will work with Yale and Vanderbilt on cancer projects

- PMLiVE

AZ signs yet another cancer immunotherapy deal

Will work with Omnis to develop viruses that target tumour cells

Pharma deals during December 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links